The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the company’s shot.

The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to protect against bird flu amid the agency’s broader efforts to reevaluate therapies that use mRNA technology.

Shares of steel companies soar after President Donald Trump says he will raise tariffs on imported steel to 50% from 25%.

Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir.

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28,

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird flu vaccine,